Published in Leukemia on June 01, 1993
Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma. Br J Cancer (2001) 0.89
A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein. Br J Cancer (2004) 0.85
Solution structure of the recombinant human oncoprotein p13MTCP1. J Biomol NMR (1998) 0.83
Refined solution structure and backbone dynamics of 15N-labeled C12A-p8MTCP1 studied by NMR relaxation. J Biomol NMR (1999) 0.79
Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med (1990) 3.21
The influence of the surface migration of gold on the growth of silicon nanowires. Nature (2006) 2.87
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J (1995) 2.73
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia (2005) 2.35
The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol (2004) 2.31
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Germanium nanowire growth below the eutectic temperature. Science (2007) 2.13
The skeletal metastatic complications of renal cell carcinoma. Int J Oncol (2001) 2.12
t(8;21) myelodysplasia, an early presentation of M2 AML. Br J Haematol (1995) 2.08
Dynamic microscopy of nanoscale cluster growth at the solid-liquid interface. Nat Mater (2003) 2.07
Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology (2001) 2.06
Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer (1997) 1.87
Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet (1990) 1.86
Waiting times and patient satisfaction in the accident and emergency department. Arch Emerg Med (1992) 1.82
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia (2011) 1.77
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia (2006) 1.69
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia (2002) 1.54
Identification of false-positive CBFbeta/MYH11 RT-PCR results. Leukemia (1999) 1.53
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features. Histopathology (2002) 1.44
Streamers: chemotactic mutants of Dictyostelium discoideum with altered cyclic GMP metabolism. J Gen Microbiol (1981) 1.43
Ten years of rituximab in NHL. Expert Opin Drug Saf (2009) 1.42
Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia (2009) 1.40
Baller Gerold syndrome and Fanconi anaemia. Am J Med Genet (1998) 1.39
Crystal structure of an ephrin ectodomain. Dev Cell (2001) 1.37
Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma. Leukemia (2005) 1.35
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. Leukemia (2009) 1.33
A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia (2010) 1.31
Case of post-primary tuberculosis and massive haematemesis. Br Med J (1974) 1.30
Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia (2003) 1.28
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene (2007) 1.28
Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood (1989) 1.28
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Kinetics of individual nucleation events observed in nanoscale vapor-liquid-solid growth. Science (2008) 1.24
Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics (1993) 1.22
Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia. Br J Haematol (2000) 1.22
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia (2004) 1.21
Sarcoidosis and thyrotoxicosis: A study of five patients. Br J Dis Chest (1976) 1.19
Yeast heat shock transcription factor contains a flexible linker between the DNA-binding and trimerization domains. Implications for DNA binding by trimeric proteins. J Biol Chem (1994) 1.19
Solution structure of the DNA-binding domain of the heat shock transcription factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. Protein Sci (1994) 1.19
Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer (2010) 1.18
Diameter-independent kinetics in the vapor-liquid-solid growth of Si nanowires. Phys Rev Lett (2006) 1.17
Postnatal encephaloclastic porencephaly--a new lesion? Arch Dis Child (1992) 1.17
Genetics of aggregation pattern mutations in the cellular slime mould Dictyostelium discoideum. J Gen Microbiol (1979) 1.16
Primary bone lymphoma: a retrospective analysis. Int J Oncol (2006) 1.16
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia (2003) 1.15
An immunophenotypic survey of malignant melanomas. Histopathology (1993) 1.13
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol (1999) 1.13
Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis. Br J Cancer (1999) 1.10
Follow-up care for cancer survivors: the views of clinicians. Br J Cancer (2009) 1.10
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer (2001) 1.10
A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Leukemia (2008) 1.08
Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections. Antimicrob Agents Chemother (1989) 1.08
Altered cGMP-phosphodiesterase activity in chemotactic mutants of Dictyostelium discoideum. FEBS Lett (1982) 1.08
Accidental poisoning in childhood. Br J Clin Pract (1973) 1.07
Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. J Infect Dis (2001) 1.07
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia (2012) 1.06
Atomic-scale transport in epitaxial graphene. Nat Mater (2011) 1.06
High-resolution scanning electron microscopy of human metaphase chromosomes. J Cell Sci (1982) 1.06
Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir. J Gen Virol (1986) 1.06
Scanning electron microscopy of the G-banded human karyotype. Exp Cell Res (1981) 1.05
Gestational trophoblastic disease in the Asian population of Northern England and North Wales. BJOG (2003) 1.05
Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res (2000) 1.05
Neutrophil function in lymphoreticular malignancy. Br J Cancer (1976) 1.04
Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab (2007) 1.04
Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease. Br J Cancer (2011) 1.04
Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial. Br J Cancer (2006) 1.03
Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins. Leukemia (2003) 1.03
Lumen formation in the developing mouse mammary gland. J Embryol Exp Morphol (1983) 1.02
Cell migration through three-dimensional gels of native collagen fibres: collagenolytic activity is not required for the migration of two permanent cell lines. J Cell Sci (1980) 1.02
Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery. Br Heart J (1975) 1.02
Serum immunoglobulin in scabies. J Invest Dermatol (1974) 1.02
Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999. Br J Haematol (2002) 1.02
Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol (2000) 1.01
Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol (2012) 1.01
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia (2002) 1.01
Characteristics of women with recurrent molar pregnancies. Gynecol Oncol (2000) 1.01
Height and Hodgkin's disease. Lancet (1976) 1.00
The fragile X: a scanning electron microscope study. J Med Genet (1983) 1.00
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia (2008) 1.00
Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis (2001) 1.00
Formation of compositionally abrupt axial heterojunctions in silicon-germanium nanowires. Science (2009) 0.99
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation. Radiother Oncol (1986) 0.99
Determination of size effects during the phase transition of a nanoscale Au-Si eutectic. Phys Rev Lett (2009) 0.99
Methotrexate-induced pericarditis and pericardial effusion; first reported case. Postgrad Med J (1995) 0.98
The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation. Int J Gynecol Cancer (2004) 0.98
Follow-up care for cancer survivors: views of the younger adult. Br J Cancer (2009) 0.98
Diagnostic lessons of mucosal melanoma with osteocartilaginous differentiation. Histopathology (1998) 0.97
Second primary malignancies after treatment for malignant lymphoma. Br J Cancer (2005) 0.97
Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate. Br J Cancer (1997) 0.97
Blurring boundaries: professional perspectives of the emergency nurse practitioner role in a major accident and emergency department. J Adv Nurs (2000) 0.96
Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs. J Infect Dis (1993) 0.95
The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients. Clin Oncol (R Coll Radiol) (2004) 0.95